loadpatents
Patent applications and USPTO patent grants for COLLINS; Stephen D..The latest application filed is for "parenteral carbamazepine formulation".
Patent | Date |
---|---|
Parenteral Carbamazepine Formulation App 20220265547 - CLOYD; James ;   et al. | 2022-08-25 |
Use of higher doses of modified release huperzine formulations Grant 11,351,120 - Collins , et al. June 7, 2 | 2022-06-07 |
Modified Release Pharmaceutical Compositions Of Huperzine And Methods Of Using The Same App 20210353552 - Collins; Stephen D. ;   et al. | 2021-11-18 |
Novel Parenteral Carbamazepine Formulation App 20210196623 - CLOYD; James ;   et al. | 2021-07-01 |
Use Of Higher Doses Of Modified Release Huperzine Formulations App 20200155456 - COLLINS; Stephen D. ;   et al. | 2020-05-21 |
Modified Release Pharmaceutical Compositions Of Huperzine And Methods Of Using The Same App 20180333365 - COLLINS; Stephen D. ;   et al. | 2018-11-22 |
Novel Parenteral Carbamazepine Formulation App 20180153797 - CLOYD; James ;   et al. | 2018-06-07 |
Parenteral carbamazepine formulation Grant 9,770,407 - Cloyd , et al. September 26, 2 | 2017-09-26 |
Parenteral carbamazepine formulation Grant 9,629,797 - Cloyd , et al. April 25, 2 | 2017-04-25 |
Compositions And Methods For Using Huperzine And Analogs Thereof App 20150335624 - COLLINS; Stephen D. ;   et al. | 2015-11-26 |
Novel Parenteral Carbamazepine Formulation App 20140080812 - CLOYD; James ;   et al. | 2014-03-20 |
Novel Parenteral Carbamazepine Formulation App 20130072476 - CLOYD; James ;   et al. | 2013-03-21 |
Novel Parenteral Carbamazepine Formulation App 20120283246 - Cloyd; James ;   et al. | 2012-11-08 |
Bumetanide, Furosemide, Piretanide, Azosemide, And Torsemide Analogs, Compositions And Methods Of Use App 20120004225 - Wanaski; Stephen ;   et al. | 2012-01-05 |
Novel Parenteral Carbamazepine Formulation App 20100204178 - Cloyd; James ;   et al. | 2010-08-12 |
Novel parenteral carbamazepine formulation App 20070185054 - Cloyd; James ;   et al. | 2007-08-09 |
Use of tiagabine for treatment of diabetic neuropathy and migraine Grant 6,872,734 - Collins , et al. March 29, 2 | 2005-03-29 |
Use of tiagabine for treatment of diabetic neuropathy and migraine App 20020103236 - Collins, Stephen D. ;   et al. | 2002-08-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.